APA (7th ed.) Citation

Ishii, T., Tanaka, Y., Kumanogoh, A., Atsumi, T., Akira, S., Tago, F., . . . Yamamuro, S. Safety, pharmacokinetics, biomarker response and efficacy of E6742: A dual antagonist of Toll-like receptors 7 and 8, in a first in patient, randomised, double-blind, phase I/II study in systemic lupus erythematosus. BMJ Publishing Group.

Chicago Style (17th ed.) Citation

Ishii, Tomonori, Yoshiya Tanaka, Atsushi Kumanogoh, Tatsuya Atsumi, Shizuo Akira, Fumitoshi Tago, Mari Aoki, and Shintaro Yamamuro. Safety, Pharmacokinetics, Biomarker Response and Efficacy of E6742: A Dual Antagonist of Toll-like Receptors 7 and 8, in a First in Patient, Randomised, Double-blind, Phase I/II Study in Systemic Lupus Erythematosus. BMJ Publishing Group.

MLA (9th ed.) Citation

Ishii, Tomonori, et al. Safety, Pharmacokinetics, Biomarker Response and Efficacy of E6742: A Dual Antagonist of Toll-like Receptors 7 and 8, in a First in Patient, Randomised, Double-blind, Phase I/II Study in Systemic Lupus Erythematosus. BMJ Publishing Group.